We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
+0.76%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$6.9B
AUM Growth
-$199M
Cap. Flow
-$157M
Cap. Flow %
-2.27%
Top 10 Hldgs %
24.04%
Holding
3,083
New
373
Increased
407
Reduced
1,584
Closed
241

Sector Composition

Rank Sector Weight
1 Technology 24.1%
2 Healthcare 12.61%
3 Financials 12.48%
4 Consumer Discretionary 12.33%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GCP
1826
DELISTED
GCP Applied Technologies Inc.
GCP
$281K ﹤0.01%
12,805
-1,996
-13% -$46.3K
BMRN icon
1827
BioMarin Pharmaceuticals
BMRN
$13.6B
$280K ﹤0.01%
3,628
-145
-4% -$11.4K
ASIX icon
1828
AdvanSix
ASIX
$427M
$280K ﹤0.01%
7,046
-1,270
-15% -$43.7K
FRG
1829
DELISTED
Franchise Group, Inc.
FRG
$280K ﹤0.01%
7,907
BJRI icon
1830
BJ's Restaurants
BJRI
$1.48B
$280K ﹤0.01%
6,694
BRMK
1831
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$279K ﹤0.01%
28,275
-4,359
-13% -$45.3K
BRKL
1832
DELISTED
Brookline Bancorp
BRKL
$278K ﹤0.01%
18,232
-1,069
-6% -$15.5K
MATW icon
1833
Matthews International
MATW
$725M
$277K ﹤0.01%
7,999
DNMR
1834
DELISTED
Danimer Scientific, Inc.
DNMR
$277K ﹤0.01%
424
-74
-15% -$54.4K
BMTC
1835
DELISTED
Bryn Mawr Bank Corp
BMTC
$277K ﹤0.01%
6,028
ROAD icon
1836
Construction Partners
ROAD
$6.9B
$276K ﹤0.01%
+8,282
New +$272K
TVTY
1837
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$276K ﹤0.01%
11,960
-3,083
-20% -$73.2K
AXSM icon
1838
Axsome Therapeutics
AXSM
$11.2B
$275K ﹤0.01%
8,348
PAYA
1839
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
$275K ﹤0.01%
25,285
WOW
1840
DELISTED
WideOpenWest
WOW
$275K ﹤0.01%
13,987
-785
-5% -$16.5K
EHTH icon
1841
eHealth
EHTH
$39.7M
$275K ﹤0.01%
6,786
FFWM
1842
DELISTED
First Foundation Inc
FFWM
$275K ﹤0.01%
+10,444
New +$250K
LUNG icon
1843
Pulmonx
LUNG
$98.4M
$274K ﹤0.01%
7,628
HRMY icon
1844
Harmony Biosciences
HRMY
$2.32B
$274K ﹤0.01%
7,149
SCS
1845
DELISTED
Steelcase
SCS
$274K ﹤0.01%
21,592
-3,421
-14% -$47.2K
EXTR icon
1846
Extreme Networks
EXTR
$3.16B
$274K ﹤0.01%
27,775
-6,308
-19% -$66.6K
YMAB
1847
DELISTED
Y-mAbs Therapeutics
YMAB
$273K ﹤0.01%
9,573
+140
+1% +$4.41K
CHEF icon
1848
Chefs' Warehouse
CHEF
$4.53B
$273K ﹤0.01%
8,378
AORT icon
1849
Artivion
AORT
$1.39B
$273K ﹤0.01%
12,229
ECOL
1850
DELISTED
US Ecology, Inc.
ECOL
$272K ﹤0.01%
8,408
-1,362
-14% -$49K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q3 2021 Portfolio in Review

As of Q3 2021, Metropolitan Life Insurance Company (MetLife) held 3,083 positions worth $6.9B, down 2.8% from $7.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q3 2021 filing shows 373 new, 407 increased, 1,584 reduced and 241 closed positions. Its largest new stake was Alphabet (Google) Class C: 878,340 shares worth $117M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $17.5M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2021 buy was Alphabet (Google) Class C: 878,340 shares worth $117M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares Russell 1000 Growth ETF in Q3 2021, an estimated $17.3M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $17.5M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $4.87M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $6.9B portfolio in Q3 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 373 new positions and closed 241 in Q3 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 2.8% quarter-over-quarter to $6.9B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2021, filed 15 Nov 2021.